YUQ-A1007

· Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YUQ-A1007, covering 2025-12-26 to 2025-12-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Oral YUQ-A1007 in Healthy Volunteers [Phase 1]